DE69824597D1 - Ikk-beta proteine, nukleinsäuren und verfahren - Google Patents

Ikk-beta proteine, nukleinsäuren und verfahren

Info

Publication number
DE69824597D1
DE69824597D1 DE69824597T DE69824597T DE69824597D1 DE 69824597 D1 DE69824597 D1 DE 69824597D1 DE 69824597 T DE69824597 T DE 69824597T DE 69824597 T DE69824597 T DE 69824597T DE 69824597 D1 DE69824597 D1 DE 69824597D1
Authority
DE
Germany
Prior art keywords
ikk
beta
nucleic acids
disclosed
beta proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69824597T
Other languages
English (en)
Other versions
DE69824597T2 (de
Inventor
V Goeddel
John Woronicz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Tularik Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tularik Inc filed Critical Tularik Inc
Application granted granted Critical
Publication of DE69824597D1 publication Critical patent/DE69824597D1/de
Publication of DE69824597T2 publication Critical patent/DE69824597T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69824597T 1997-07-01 1998-07-01 Ikk-beta proteine, nukleinsäuren und verfahren Expired - Fee Related DE69824597T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US88711497A 1997-07-01 1997-07-01
US887114 1997-07-01
US890853 1997-07-10
US08/890,853 US5851812A (en) 1997-07-01 1997-07-10 IKK-β proteins, nucleic acids and methods
PCT/US1998/013783 WO1999001542A1 (en) 1997-07-01 1998-07-01 IKK-β PROTEINS, NUCLEIC ACIDS AND METHODS

Publications (2)

Publication Number Publication Date
DE69824597D1 true DE69824597D1 (de) 2004-07-22
DE69824597T2 DE69824597T2 (de) 2005-06-09

Family

ID=27128822

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69824597T Expired - Fee Related DE69824597T2 (de) 1997-07-01 1998-07-01 Ikk-beta proteine, nukleinsäuren und verfahren

Country Status (10)

Country Link
US (3) US5851812A (de)
EP (1) EP1005540B1 (de)
JP (2) JP3472584B2 (de)
AT (1) ATE269402T1 (de)
AU (1) AU725477B2 (de)
CA (1) CA2294516C (de)
DE (1) DE69824597T2 (de)
DK (1) DK1005540T3 (de)
ES (1) ES2218839T3 (de)
WO (1) WO1999001542A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU726383B2 (en) * 1996-08-26 2000-11-02 Signal Pharmaceuticals, Inc. Stimulus-inducible I (KAPPA)B kinase (IKK) signalsome
US5972674A (en) 1996-08-26 1999-10-26 Signal Pharmaceuticals, Inc. Stimulus-inducible protein kinase complex and methods of use therefor
AU740622B2 (en) * 1997-02-25 2001-11-08 Regents Of The University Of California, The IkB kinase, subunits thereof, and methods of using same
US6235512B1 (en) * 1997-07-01 2001-05-22 Tularik Inc. IKK-α proteins, nucleic acids and methods
EP0897009A3 (de) * 1997-08-04 1999-06-09 Smithkline Beecham Plc HKABY60 Polypeptide
US6087169A (en) * 1997-08-04 2000-07-11 Smithkline Beecham Plc HKABY60: polynucleotide encoding a helix-loop-helix ubiquitous kinase family polypeptide
US6242253B1 (en) * 1997-10-09 2001-06-05 Regents Of The University Of California IkB kinase, subunits thereof, and methods of using same
US6030834A (en) * 1997-12-30 2000-02-29 Chiron Corporation Human IKK-beta DNA constructs and cells
JP2003526608A (ja) * 1998-10-15 2003-09-09 バイオイメージ エイ／エス 再分布及び／又は標的化での干渉によって得られる特異的治療の介入
CN102816743A (zh) * 1998-12-10 2012-12-12 信号药物公司 调节NF-κB的人遍在蛋白连接酶E3
UA73492C2 (en) 1999-01-19 2005-08-15 Aromatic heterocyclic compounds as antiinflammatory agents
EP1157026A1 (de) 1999-02-22 2001-11-28 Boehringer Ingelheim Pharmaceuticals Inc. Polyheterocyclische verbindungen mit entzündungshemmender wirkung
WO2000055139A2 (en) 1999-03-12 2000-09-21 Boehringer Ingelheim Pharmaceuticals, Inc. Heterocyclic urea and related compounds useful as anti-inflammatory agents
DE60023853T2 (de) 1999-03-12 2006-05-24 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield Aromatische heterozyklische verbindungen als antientzündungwirkstoffe
ATE312823T1 (de) * 1999-07-09 2005-12-15 Boehringer Ingelheim Pharma Verfahren zur herstellung heteroarylsubstituierter ureaverbindungen
AU6898700A (en) 1999-08-10 2001-03-05 Joslin Diabetes Center Inc. Method for identifying compounds for treatment of insulin resistance
US6630312B2 (en) 1999-08-10 2003-10-07 Joslin Diabetes Center, Inc. Method for identifying compounds for treatment of insulin resistance
AU2007202315B2 (en) * 1999-09-30 2009-11-19 Yale University Anti-inflammatory compounds and uses thereof
US6864355B1 (en) 2000-05-02 2005-03-08 Yale University Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain
EP1242616A2 (de) * 1999-12-06 2002-09-25 Axxima Pharmaceuticals Aktiengesellschaft Verfahren zur identifizierung und quantifizierung von kinase-hemmstoffen
EP1248856A2 (de) * 1999-12-23 2002-10-16 Xantos Biomedicine AG Screening-verfahren für nukleinsäuren
US6525046B1 (en) 2000-01-18 2003-02-25 Boehringer Ingelheim Pharmaceuticals, Inc. Aromatic heterocyclic compounds as antiinflammatory agents
US6608052B2 (en) 2000-02-16 2003-08-19 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as anti-inflammatory agents
US7049395B2 (en) * 2000-05-02 2006-05-23 Yale University Anti-inflammatory compounds and uses thereof
US20030044852A1 (en) * 2000-08-10 2003-03-06 Joslin Diabetes Center, Inc., A Massachusetts Corporation Methods for treatment of insulin resistance
US6869956B2 (en) * 2000-10-03 2005-03-22 Bristol-Myers Squibb Company Methods of treating inflammatory and immune diseases using inhibitors of IκB kinase (IKK)
CA2436770A1 (en) * 2001-02-01 2002-08-08 James R. Burke Methods of treating inflammatory and immune diseases using inhibitors of ikb kinase (ikk)
DE10115073A1 (de) * 2001-03-27 2002-10-10 Procorde Gmbh Verwendung von Inhibitoren von IKK-ß und Verfahren zum Auffinden solcher Inhibitoren
WO2002082082A2 (en) * 2001-04-09 2002-10-17 Boehringer Ingelheim Pharmaceuticals, Inc. Fluorescence polarization assay
AU2002352519A1 (en) * 2001-11-09 2003-05-26 The General Hospital Corporation Methods for treating ischemic reperfusion injury using ikb kinase-beta inhibitors
US20030118575A1 (en) * 2001-12-11 2003-06-26 Boehringer Ingelheim Pharmaceuticals, Inc. Method for administering BIRB 796 BS
EP1480973B1 (de) * 2002-02-25 2008-02-13 Boehringer Ingelheim Pharmaceuticals Inc. 1,4-disubstituierte benzokondensierte cycloalkyl-harnstoffverbindungen zur behandlung von zytokinvermittelten erkrankungen
WO2005101019A2 (en) * 2004-04-12 2005-10-27 University Of Vermont And State Agricultural College Detection of nitrosylated proteins
CA2646316C (en) 2006-03-15 2016-05-24 Theralogics, Inc. Methods of treating muscular wasting diseases using nf-kb activation inhibitors
AU2007253677B2 (en) * 2006-05-22 2011-02-10 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of IKK-B gene
KR101591482B1 (ko) 2008-05-28 2016-02-03 레베라겐 바이오파마 인코포레이티드 질환의 치료를 위한 ＮＦ-κＢ 의 비호르몬성 스테로이드 조절제
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU726383B2 (en) * 1996-08-26 2000-11-02 Signal Pharmaceuticals, Inc. Stimulus-inducible I (KAPPA)B kinase (IKK) signalsome
AU740622B2 (en) * 1997-02-25 2001-11-08 Regents Of The University Of California, The IkB kinase, subunits thereof, and methods of using same
US5843721A (en) * 1997-07-03 1998-12-01 Tularik Inc. Nucleic acids encoding human NIK protein
EP0897009A3 (de) * 1997-08-04 1999-06-09 Smithkline Beecham Plc HKABY60 Polypeptide
US6030834A (en) * 1997-12-30 2000-02-29 Chiron Corporation Human IKK-beta DNA constructs and cells

Also Published As

Publication number Publication date
JP2001510347A (ja) 2001-07-31
EP1005540A1 (de) 2000-06-07
US5916760A (en) 1999-06-29
EP1005540A4 (de) 2003-04-02
DE69824597T2 (de) 2005-06-09
US5851812A (en) 1998-12-22
ES2218839T3 (es) 2004-11-16
JP3472584B2 (ja) 2003-12-02
AU8283798A (en) 1999-01-25
ATE269402T1 (de) 2004-07-15
CA2294516C (en) 2003-10-21
EP1005540B1 (de) 2004-06-16
WO1999001542A1 (en) 1999-01-14
DK1005540T3 (da) 2004-10-18
AU725477B2 (en) 2000-10-12
CA2294516A1 (en) 1999-01-14
US5939302A (en) 1999-08-17
JP2003274984A (ja) 2003-09-30

Similar Documents

Publication Publication Date Title
DE69824597D1 (de) Ikk-beta proteine, nukleinsäuren und verfahren
DE69840387D1 (de) Nik proteine, nukleinsäure sowie verfahren
DE69826493D1 (de) Ikk-alpha proteine, nukleinsäuren und verfahren
DE69533564D1 (de) Effektor-Proteine für Rapamycin
PT973794E (pt) Receptores de netrina
DE69732535D1 (de) Oligonucleotidzusammenstellung und verfahren zur regulierung der protein b7 expression
CA2281895A1 (en) Ikb kinases
WO1996015144A3 (en) Chromosome 21 gene marker, compositions and methods using same
DE69816467D1 (de) Robo: eine familie polypeptiden und nukleinesäuren wirksam in nervenzellleitung
DE69831500T2 (de) Humane checkpointkinase, hcds1, zusammensetzungen und verfahren
WO2001014420A3 (en) Novel members of the plexin family and uses thereof
WO2002040668A3 (de) Proteine und den proteinen zugrundeliegende dna-sequenzen mit funktion bei entzündungsereignissen
MXPA02008239A (es) Gen humano de la esquizofrenia.
ATE88500T1 (de) Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel.
DE69928395D1 (de) Cyclin-e2 proteine und dafür kodierende gene
EP1757616A3 (de) Semaphorinrezeptoren
WO1998011234A3 (en) Human protein kinases
WO2001040313A3 (en) Feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
DE60044038D1 (de) Xylosyltransferase und isoformen
WO2000018907A3 (de) Antisense-sequenzen für die hemmung der expression des adhäsionsmoleküls icam-1
WO2001036478A3 (en) Methods and compositions relating to bactericidal/permeability increasing factor-like polypeptides and polynucleotides
WO2005054426A3 (en) Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof
WO2003044160A3 (en) Novel molecules of the card related protein family and uses thereof

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: AMGEN INC., THOUSAND OAKS, CALIF., US

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee